Follow-up probiotic ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 193 | プラダー・ウィリ症候群 | 1 |
193. プラダー・ウィリ症候群
臨床試験数 : 111 / 薬物数 : 120 - (DrugBank : 30) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 103
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04685057 (ClinicalTrials.gov) | January 11, 2021 | 2/12/2020 | Probiotic Treatment for Prader-Willi Syndrome | Probiotics as a Long-term Treatment Strategy for Prader-Willi Syndrome | Prader-Willi Syndrome | Dietary Supplement: Placebo;Dietary Supplement: Probiotic;Dietary Supplement: Follow-up probiotic | Fundació Sant Joan de Déu | NULL | Enrolling by invitation | 6 Years | 30 Years | All | 50 | Phase 1/Phase 2 | Spain |